Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024
Compare Balance Sheet Results of Bacil Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.97
23.71
-9.74
-41.08%
Share Warrants & Outstandings
Total Reserve
11.46
0.95
10.51
1,106.32%
Shareholder's Funds
25.43
24.65
0.78
3.16%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.05
0.00
-0.05
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
-0.05
0.00
-0.05
0.00%
Current Liabilities
Trade Payables
0.00
0.00
0.00
0.00%
Other Current Liabilities
0.00
0.14
-0.14
-100.00%
Short Term Borrowings
0.16
0.44
-0.28
-63.64%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.17
0.57
-0.40
-70.18%
Total Liabilities
25.55
25.23
0.32
1.27%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.06
0.05
0.01
20.00%
Less: Accumulated Depreciation
0.06
0.01
0.05
500.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.04
-0.04
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
21.36
0.00
21.36
0.00%
Long Term Loans & Advances
1.28
0.02
1.26
6,300.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
22.64
0.07
22.57
32,242.86%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
0.60
-0.60
-100.00%
Cash and Bank
2.86
21.30
-18.44
-86.57%
Other Current Assets
0.00
0.00
0.00
0.00%
Short Term Loans and Advances
0.05
3.26
-3.21
-98.47%
Total Current Assets
2.91
25.16
-22.25
-88.43%
Net Current Assets (Including Current Investments)
2.74
24.59
-21.85
-88.86%
Total Current Assets Excluding Current Investments
2.91
25.16
-22.25
-88.43%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.55
25.23
0.32
1.27%
Contingent Liabilities
0.00
0.49
-0.49
-100.00%
Total Debt
0.16
0.44
-0.28
-63.64%
Book Value per share (adjusted)
18.20
10.40
7.80
75.00%
Annual - Borrowings
Borrowings 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Annual - Investments
Investments 21.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024
Annual - Current Assets
Current Assets 2.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024
